Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia

University Hospital Tuebingen · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
relapse
all, childhood b-cell, acute lymphoid leukemia relapse, acute lymphocytic leukemia refractory, cd19 positive, refractory to standard treatment, relapse, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 800426
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.